Research ArticleTheranostics
Histologically Confirmed Diagnostic Efficacy of 18F-rhPSMA-7 PET for N-Staging of Patients with Primary High-Risk Prostate Cancer
Markus Kroenke, Alexander Wurzer, Kristina Schwamborn, Lena Ulbrich, Lena Jooß, Tobias Maurer, Thomas Horn, Isabel Rauscher, Bernhard Haller, Michael Herz, Hans-Jürgen Wester, Wolfgang A. Weber and Matthias Eiber
Journal of Nuclear Medicine May 2020, 61 (5) 710-715; DOI: https://doi.org/10.2967/jnumed.119.234906
Markus Kroenke
1Department of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Alexander Wurzer
2Technical University of Munich, Munich, Germany
Kristina Schwamborn
3Institute of Pathology, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Lena Ulbrich
1Department of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Lena Jooß
1Department of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Tobias Maurer
4Martini-Klinik and Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
Thomas Horn
5Department of Urology, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany; and
Isabel Rauscher
1Department of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Bernhard Haller
6Institute of Medical Informatics, Statistics and Epidemiology, School of Medicine, Technical University of Munich, Munich, Germany
Michael Herz
1Department of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Hans-Jürgen Wester
2Technical University of Munich, Munich, Germany
Wolfgang A. Weber
1Department of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Matthias Eiber
1Department of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue 5
May 1, 2020
Histologically Confirmed Diagnostic Efficacy of 18F-rhPSMA-7 PET for N-Staging of Patients with Primary High-Risk Prostate Cancer
Markus Kroenke, Alexander Wurzer, Kristina Schwamborn, Lena Ulbrich, Lena Jooß, Tobias Maurer, Thomas Horn, Isabel Rauscher, Bernhard Haller, Michael Herz, Hans-Jürgen Wester, Wolfgang A. Weber, Matthias Eiber
Journal of Nuclear Medicine May 2020, 61 (5) 710-715; DOI: 10.2967/jnumed.119.234906
Histologically Confirmed Diagnostic Efficacy of 18F-rhPSMA-7 PET for N-Staging of Patients with Primary High-Risk Prostate Cancer
Markus Kroenke, Alexander Wurzer, Kristina Schwamborn, Lena Ulbrich, Lena Jooß, Tobias Maurer, Thomas Horn, Isabel Rauscher, Bernhard Haller, Michael Herz, Hans-Jürgen Wester, Wolfgang A. Weber, Matthias Eiber
Journal of Nuclear Medicine May 2020, 61 (5) 710-715; DOI: 10.2967/jnumed.119.234906
Jump to section
Related Articles
Cited By...
- Validation of 18F-rhPSMA-7 and 18F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate Cancer
- Synthesis and Preclinical Evaluation of 177Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate Cancer
- 18F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Curative-Intent Radiation Therapy: A Bicentric Retrospective Study
- Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
- The Influence of Specific Activity on the Biodistribution of 18F-rhPSMA-7.3: A Retrospective Analysis of Clinical PET Data
- Detection Efficacy of 18F-rhPSMA-7.3 PET/CT and Impact on Management in Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Before Potential Salvage Treatment
- Matched-Pair Comparison of 68Ga-PSMA-11 and 18F-rhPSMA-7 PET/CT in Patients with Primary and Biochemical Recurrence of Prostate Cancer: Frequency of Non-Tumor-Related Uptake and Tumor Positivity
- Comparative Preclinical Biodistribution, Dosimetry, and Endoradiotherapy in Metastatic Castration-Resistant Prostate Cancer Using 19F/177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T
- Diagnostic Accuracy of 18F-PSMA-1007 PET/CT Imaging for Lymph Node Staging of Prostate Carcinoma in Primary and Biochemical Recurrence